APRIL 20246ReviewMedical CareAutism Spectrum Disorder (ASD) is a complex disorder that affects millions of individuals and their families worldwide. As the prevalence of autism continues to rise, so does the demand for effective treatments. Applied Behavior Analysis (ABA) therapy stands out as a gold standard in the field of autism intervention. Improved insurance coverage and higher investments have further driven the sector's growth. By utilizing fundamental behavioral techniques, including positive reinforcement and outcome-based strategies, ABA therapy not only treats ASD but also promotes the development of essential life skills, ensuring its continued success.The autism therapy market is experiencing significant technological advances that are propelling its growth. With the market projected to reach $3.42 bn by 2030, a CAGR of 6.60 percent is expected from 2023 to 2030. The increased incidence of autism and pervasive developmental disorder (PDD) is a major driver of this growth. Extensive research studies, particularly in the safety and efficacy of drugs for ASD patients, are contributing to market expansion. The stimulants segment leads the market, largely due to the wide availability and accessibility of such drugs for patients. Augmented reality offers new ways to engage children with ASD, while robots are proving effective in teaching social skills and maintaining focus during therapy sessions.This Medical Care Review edition highlights the key developments in ABA therapy through thought leadership articles from Dawn Ayala, BS, RRT, AE-C, Director of Respiratory Therapy Services at Bethany Children's Health Center, and Truett Smith, Director of Advan at Atrium Health.Sohail Masood highlights the home infusion industry's evolving landscape, including the increased influx of injectable drugs for various conditions and the potential for gene therapy. In this edition we hope you find the appropriate company suited to your business requirements.Let us know your thoughts.TECHNOLOGICAL ADVANCES TRANSFORMING AUTISM THERAPYEDITORIALManaging EditorLyra HawthorneEditorial StaffAaron PaulGina ClumskyJoe PhillipJames SmithMark RobertYenny TurnerCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@medicalcarereview.comeditor@medicalcarereview.commarketing@medicalcarereview.comVisualizerSamaelAPRIL 2024, volume 02 - Issue 02 Published by ValleyMedia, Inc. 600 S ANDREWS AVE STE 405,FT LAUDERDALE, FL 33301 To subscribe to Medical Care ReviewVisit www.medicalcarereview.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsLyra HawthorneManaging Editoreditor@medicalcarereview.com
< Page 5 | Page 7 >